Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV
Alcohol: Clinical and Experimental Research · 2023
DOI: 10.1111/acer.15031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol: Clinical and Experimental Research, 2023. Verfasst von Nicolas Bertholet und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Addiction Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Alcoholism, HIV Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Alcohol use has been linked to worse human immunodeficiency virus (HIV) immunologic/virologic outcomes, yet few studies have explored the effects of alcohol use disorder (AUD). This study assessed whether AUD severity is associated with HIV viral suppression and CD4 count in the three cohorts of the Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Consortium.
Methods
People with HIV (PWH) in Uganda ( n = 301), Russia ( n = 400), and Boston ( n = 251), selected in‐part based on their alcohol use, were included in analyses. Logistic and linear regressions were used to assess the cross‐sectional associations between AUD severity (number of DSM‐5 diagnostic criteria) and (1) HIV viral suppression, and (2) CD4 count (cells/mm 3 ) adjusting for covariates. Analyses were conducted separately by site.
Results
The proportion of females was 51% (Uganda), 34% (Russia), and 33% (Boston); mean age (SD) was 40.7 (9.6), 38.6 (6.3), and 52.1 (10.5), respectively. All participants in Uganda and all but 27% in Russia and 5% in Boston were on antiretroviral therapy. In Uganda, 32% met criteria for AUD, 92% in Russia, and 43% in Boston. The mean (SD) number of AUD criteria was 1.6 (2.4) in Uganda, 5.6 (3.3) in Russia, and 2.4 (3.1) in Boston. Most participants had HIV viral suppression (Uganda 92%, Russia 57%, Boston 87%); median (IQR) CD4 count was 673 (506, 866), 351 (201, 542), and 591 (387, 881), respectively. In adjusted models, there were no associations between AUD severity and HIV viral suppression: adjusted odds ratios (AOR) (95%CI) per 1 additional AUD criterion in Uganda was 1.08 (0.87, 1.33); Russia 0.98 (0.92, 1.04); and Boston 0.95 (0.84, 1.08) or CD4 count: mean difference (95%CI) per 1 additional criterion: 5.78 (−7.47, 19.03), −3.23 (−10.91, 4.44), and −8.18 (−24.72, 8.35), respectively.
Conclusions
In three cohorts of PWH, AUD severity was not associated with HIV viral suppression or CD4 count. PWH with AUD in the current era of antiretroviral therapy can achieve virologic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Addiction Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Department of Medicine, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
- Department of Community Health Sciences, Boston University School of Public Health, Boston, Massachusetts, USA.
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
- Department of Medicine, University of California San Francisco, San Francisco, California, USA.
- Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
ORCID-Profile: Nicolas Bertholet, Richard Saitz, Judith A Hahn, Theresa W Kim, Jeffrey H Samet
Förderung
- NIAAA NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Bertholet, N., Saitz, R., Hahn, J. A., Heeren, T. C., Emenyonu, N. I., Freiberg, M., Winter, M. R., Kim, T. W., Magane, K. M., Lloyd-Travaglini, C., Fatch, R., Bryant, K., Forman, L. S., Rateau, L., Blokhina, E., Muyindike, W. R., Gnatienko, N., & Samet, J. H. (2023). Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV. Alcohol: Clinical and Experimental Research. https://doi.org/10.1111/acer.15031
Vancouver
Bertholet N, Saitz R, Hahn JA, Heeren TC, Emenyonu NI, Freiberg M, et al. Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV. Alcohol: Clinical and Experimental Research. 2023. doi:10.1111/acer.15031
BibTeX
@article{Bertholet2023,
author = {Bertholet, Nicolas and Saitz, Richard and Hahn, Judith A and Heeren, Timothy C and Emenyonu, Nneka I and Freiberg, Matthew and Winter, Michael R and Kim, Theresa W and Magane, Kara M and Lloyd-Travaglini, Christine and Fatch, Robin and Bryant, Kendall and Forman, Leah S and Rateau, Lindsey and Blokhina, Elena and Muyindike, Winnie R and Gnatienko, Natalia and Samet, Jeffrey H},
title = {Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV},
journal = {Alcohol: Clinical and Experimental Research},
year = {2023},
doi = {10.1111/acer.15031}
}
EUVIMED